Determinants of Early Cystic Fibrosis Lung Disease
1 other identifier
observational
61
1 country
1
Brief Summary
The overall objective of this study is to determine the impact early nutritional and respiratory indices have on early CF lung disease. This knowledge will guide clinical management of infants with CF, who are now primarily diagnosed through newborn screening.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 8, 2018
CompletedFirst Submitted
Initial submission to the registry
June 25, 2018
CompletedFirst Posted
Study publicly available on registry
July 6, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 6, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 6, 2019
CompletedJune 22, 2022
June 1, 2022
9 months
June 25, 2018
June 16, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Lung function
Forced expiratory volume in 0.5 seconds
24 months
Secondary Outcomes (2)
Lung function - FRC
24 months
Lung function - MBW
24 months
Study Arms (3)
Nutrition and Infant PFT
To examine the relationship between nutritional status (weight-for-age (WFA) and weight-for-length (WFL)) at 6 months of age and lung function at 1-2 years of age in infants with CF.
Nutrition and Lung Clearance Index
To examine the relationship between nutritional status (WFA and WFL) in infants with CF at 12 months of age and the lung clearance index (LCI) at 3-5 years of age.
Passive Tidal Breathing and Infant PFT
To delineate the relationship between passive tidal breathing lung function testing in infants with CF at 4-8 weeks of age and subsequent lung function at 6-12 months of age.
Interventions
Assessed through the raised volume rapid thoracoabdominal compression technique and plethysmography
The Lung Clearance Index is derived from the Multiple Breath Washout test. It is the cumulative exhaled volume (the volume of gas needed to wash out resident gas mixture out of the lungs) divided by the FRC. The FRC is the amount of air left in the lungs after normal exhalation.
During quiet sleep, tidal breathing flow-volume curves are obtained. The tPEF/tE is calculated by taking the time it takes to reach peak expiratory flow divided by the total peak expiratory time.
Eligibility Criteria
Infants and preschoolers with cystic fibrosis diagnosed by newborn screen.
You may qualify if:
- Informed consent by a parent or legal guardian
- A confirmed diagnosis of CF by newborn screening and either a documented sweat chloride of at least 60 mEq/L by quantitative pilocarpine iontophoresis or a genotype with two CF-causing mutations
- One month to five years of age.
You may not qualify if:
- Chronic lung disease not due to CF
- Contraindications to sedation, including structural abnormalities of the upper airway or chest wall and severe gastroesophageal reflux
- Gestational age \< 36 weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Riley Hospital for Children
Indianapolis, Indiana, 46202, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Heather Muston, MD
Indiana University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Clinical Pediatrics
Study Record Dates
First Submitted
June 25, 2018
First Posted
July 6, 2018
Study Start
May 8, 2018
Primary Completion
February 6, 2019
Study Completion
February 6, 2019
Last Updated
June 22, 2022
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will not share